Comparison of Once- Versus Twice-Daily Administration of long-acting insulin Detemir in children with type 1 diabetes
Phase 3
Recruiting
- Conditions
- Diabetes mellitus type 1.Type 1 diabetes mellitus without complications
- Registration Number
- IRCT20181106041574N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Diabetes mellitus type 1 (according to ISPAD 2014 criteria)
Age at diagnosis: 2-6 years old
Lasting at least 1 year since diagnosis
Desire to use insulin Detemir
Exclusion Criteria
The use of drugs that are effective on controlling diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c. Timepoint: 3 Months. Method of measurement: lab.
- Secondary Outcome Measures
Name Time Method